stockrowBoston Scientific Corporation
BSX Healthcare Medical Devices
Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024.
- Revenue
- +1.44%
- EPS
- −21.6%
- Free cash flow
- −25.3%
- Total debt
- +3.04%
Quarter to September 2026, against a year earlier
Follow BSX
Alert me
Boston Scientific Corporation (BSX) Revenue growth
Boston Scientific Corporation's revenue growth over the twelve months to 30 September 2026 was 8.87%, down 11.0 percentage points from fiscal 2025 (19.9%). Over the past ten years it has ranged from −7.66% (fiscal 2020) to 19.9% (fiscal 2021); the current reading is higher than 91% of that period. That is below the Medical Devices industry median of 10.4% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 19.9% | 2.26 |
| FY2024 | 17.6% | 5.32 |
| FY2023 | 12.3% | 5.61 |
| FY2022 | 6.68% | (13.24) |
| FY2021 | 19.9% | 27.58 |
| FY2020 | −7.66% | (16.94) |
| FY2019 | 9.28% | 0.71 |
| FY2018 | 8.57% | 0.68 |
| FY2017 | 7.89% | (4.27) |
| FY2016 | 12.2% | 10.85 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 1.44% | (6.09) |
| Jun 2026 | 7.53% | (4.05) |
| Mar 2026 | 11.6% | (4.27) |
| Dec 2025 | 15.9% | (4.49) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| EW Edwards Lifesciences Corporation compare | 13.4% |
| DXCM DexCom, Inc. compare | 13.0% |
| ABT Abbott Laboratories compare | 10.0% |
| MDT Medtronic PLC compare | 9.77% |
| BSX Boston Scientific Corporation | 8.87% |
| STE STERIS plc compare | 8.12% |
| PHG Koninklijke Philips N.V. compare | 7.98% |
| SYK Stryker Corporation compare | 7.87% |
| GEHC GE HealthCare Technologies Inc. compare | 6.87% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on BSX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement